Union Minister Piyush Goyal said he held a meeting with Janet Truncale, Global Chair and CEO of EY, to discuss India's growing role in glob...

India faces a challenging global economic outlook for 2026-27. Geopolitical tensions and volatile oil prices are key concerns. However, Ind...

Bernstein has initiated coverage on six Indian pharma stocks, with Zydus Lifesciences as its top choice. The brokerage sees strong future g...

The Karnataka Bioeconomy Report 2025, released by the state's IT/BT ministry, in collaboration with the Association of Biotechnology Led En...

The Union Budget 2026-27 focuses on fortifying the Indian economy against global volatility through strategic investments in technology, he...

India Inc has welcomed the Union Budget 2026-27. Industry leaders believe it is a budget for the real economy. It focuses on enhancing Indi...

With its 2026 Union Budget, India places a spotlight on the future of healthcare, specifically targeting biologics and biosimilars. A visio...

Union Budget 2026: With the announcement of the 'Biopharma Shakti' initiative, India is gearing up to take the world stage in biopharmaceut...

Union Budget 2026: Finance Minister Nirmala Sitharaman has presented a six-point plan to boost India's economy. The strategy prioritizes ma...

The joint report by the USA India Chamber of Commerce & PwC India titled, “Clinical Trial opportunities in India” which will be released at...

“A young scientist joining a company like Syngene can travel the world scientifically without ever having to leave Bengaluru. It provides o...

Ahead of the 14th edition of the annual BioPharma and Healthcare Summit, that bring stakeholders from India and the United States on one pl...

It is likely to take some time before we can actually start very aggressively marketing globally from the Malaysia facility.

The McKinsey report commissioned by the US-India Chamber of Commerce would be released at the US-India BioPharma and Healthcare Summit 2013...

Emerging markets will drive 70% of growth in the pharma industry and India will require supportive policies to leverage the BioPharma.

The biotech industry, without the life sciences education component, recorded revenue growth of 21.5 per cent vis-a-vis 2009-10 revenues of...

Notwithstanding the current global economic crisis, India's pharmaceutical industry and its health care market are expected to grow rapidly...